Concerns regarding drug-drug interactions and overlapping toxicities of antiretroviral agents and chemotherapy agents are now fairly easily managed using newer HIV medications (Table 4). Preferred regimens at our institution have evolved over time; although we initially avoided protease inhibitors and prefer...
As expected, all of the antibodies tested blocked the binding of the autologous biotinylated monoclonal (yellow boxes in Figure 4A), while control human anti-HIV antibody 10–1,074 failed to block any of the anti-HBs antibodies. The competition ELISA identified three mutually exclusive groups of...
RESULTS A total of 141,595 patients met study criteria. A large majority (n = 124,464, 87.9%) were in the no-therapy cohort, 14,850 (10.5%) were in the monotherapy cohort, and 2281 (1.6%) were in the combination therapy cohort. The majority of monotherapy patients initiated st...